• About us
• Contact

Advertisement

Product › Details

SAF-301 (Lysogene)

	Next higher product group	gene therapy_o
	Status	2012-06-14 development p1 existent
	Organisation	Lysogene S.A. (Euronext Paris: LYS)

Record changed: 2023-07-10

Advertisement

More documents for gene therapy_o

• [1] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....
• [2] MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY....
• [3] EG 427. (7/13/23). "Press Release: EG 427 Announces Final Series A Closing, Achieving €18 Million in Total Funds Raised". Paris....
• [4] Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam....
• [5] Sio Gene Therapies Inc.. (1/31/22). "Press Release: Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition". New York, NY & Durham, NC....
• [6] European Invesmtent Bank (EIB). (12/24/21). "Press Release: France – Lysogene Enters into a Loan Agreement of €15 Million with the EIB"....
• [7] Genenta Science S.p.A.. (12/17/21). "Press Release: Genenta Closes Its Upsized Initial Public Offering of American Depository Shares". Milan & New York, NY....
• [8] Genenta Science S.p.A.. (12/14/21). "Press Release: Genenta Announces Pricing of Upsized Initial Public Offering". Milan & New York, NY....
• [9] Capsida Biotherapeutics Inc.. (12/7/21). "Press Release: Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO". Thousand Oaks, CA....
• [10] Genenta Science S.p.A.. (11/10/21). "Press Release: Genenta Announces Filing of Registration Statement for Proposed Initial Public Offering". Milan & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.